Dr. Colleen Delaney

For the Media

Dr. Colleen Delaney

Dr. Colleen Delaney is a member of Fred Hutch's Clinical Research Division and a director of Fred Hutch's Cord Blood Program. Her laboratory and clinical research is focused on the development of revolutionary techniques for improving outcomes from transplantation and changing the standards of care to help prevent infection and speed recovery after transplant or chemotherapy.

Resources for more information

  • Overview of Colleen Delaney’s Research
    Her vision is to create a therapy that can become FDA approved and be given to patients around the world.
  • Colleen Delaney – Brief Curriculum Vitae
    Appointments, affiliations and researcher interests.
  • The Delaney Lab
    Laboratory and clinical research components of the Cord Blood Program, led by Dr. Delaney, are focused on the development of revolutionary techniques for improving outcomes from transplantation and changing the standards of care to help prevent infection and speed recovery after transplant or chemotherapy.  This is being done by harnessing cord blood's lifesaving power.
  • Cord Blood Program
    Program researchers continue to develop ways to make immunity-boosting therapies even more effective. They are showing these treatments can induce remissions for patients with advanced tumors and are likely to have broad utility across many cancers. 

FOR THE MEDIA

Hutch Team

For more information or to arrange an interview, please contact Fred Hutch at (206) 667-2210 or email our media relations team.


 

Photos / Graphics / Video

Download

Download photos and view video of Colleen Delaney.

Related Stories


At Fred Hutchinson Cancer Research Center, home to three Nobel laureates, interdisciplinary teams of world-renowned scientists seek new and innovative ways to prevent, diagnose and treat cancer, HIV/AIDS and other life-threatening diseases. Fred Hutch’s pioneering work in bone marrow transplantation led to the development of immunotherapy, which harnesses the power of the immune system to treat cancer with minimal side effects. An independent, nonprofit research institute based in Seattle, Fred Hutch houses the nation’s first and largest cancer prevention research program, as well as the clinical coordinating center of the Women’s Health Initiative and the international headquarters of the HIV Vaccine Trials Network. Private contributions are essential for enabling Fred Hutch scientists to explore novel research opportunities that lead to important medical breakthroughs. For more information visit fredhutch.org or follow Fred Hutch on Facebook, Twitter or YouTube.